Results 91 to 100 of about 3,155 (113)

Belantamab mafodotin: an important treatment option for vulnerable patients with triple class exposed relapsed and/or refractory multiple myeloma. [PDF]

Haematologica
Mateos MV, Weisel K, Terpos E, Delimpasi S, Kastritis E, Zamagni E, Delforge M, Ocio E, Katodritou E, Gay F, Larocca A, Leleu X, Otero PR, Schjesvold F, Cavo M, Dimopoulos MA.   +15 more
europepmc   +1 more source

O TEATRO ANARQUISTA E O CONCEITO DE ARTE NA IMPRENSA OPERÁRIA DE 1901 A 1922

Projeto História, 2012
Eduardo Gramani Hipólide
doaj  

Cross-Cultural Adaptation and Translation of the Neck Dissection Impairment Index (NDII) into Spanish. [PDF]

J Otolaryngol Head Neck Surg
Vargas L, Langlie J, McGee C, Ma R, Perdigon O, Lai SY, Chepeha D, Civantos FJ.   +7 more
europepmc   +1 more source

[Association between environmental noise exposure and sleep quality in adults living in Medellín, Colombia, 2022: an exploratory study]. [PDF]

Cad Saude Publica
Rojas-Sánchez OA, Ochoa-Villegas J, Marín D, Piñeros-Jiménez JG, Rodriguez-Villamizar LA.   +4 more
europepmc   +1 more source

[Anales del Sistema Sanitario de Navarra in 2025: Progress continues]. [PDF]

An Sist Sanit Navar
Godoy P, Beorlegui C.
europepmc   +1 more source

Tinostamustine (EDO-S101), an Alkylating Deacetylase Inhibitor, Enhances the Efficacy of Daratumumab in Multiple Myeloma by Upregulation of CD38 and NKG2D Ligands. [PDF]

Int J Mol Sci
Díaz-Tejedor A, Rodríguez-Ubreva J, Ciudad L, Lorenzo-Mohamed M, González-Rodríguez M, Castellanos B, Sotolongo-Ravelo J, San-Segundo L, Corchete LA, González-Méndez L, Martín-Sánchez M, Mateos MV, Ocio EM, Garayoa M, Paíno T.   +14 more
europepmc   +1 more source

Daratumumab Versus Control Treatment: A Systematic Review and Meta-analysis Study of Survival Outcomes Among Multiple Myeloma Patients : Survival Outcomes of Multiple Myeloma Treatment with Daratumumab. [PDF]

Galen Med J
Salajegheh P, Salajegheh A, Yazdi Yahyaabadi F, Yazdi F.   +3 more
europepmc   +1 more source